Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.
Rheumatology (Oxford)
; 62(5): 1870-1876, 2023 05 02.
Article
in En
| MEDLINE
| ID: mdl-36111858
Full text:
1
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Lung Diseases, Interstitial
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2023
Type:
Article